Filter
5630
Text search:
drug
development
Featured
Recommendations
499
New Publications
1474
Language
Document type
No document type
3317
Studies & Reports
912
Guidelines
720
Manuals
257
Strategic & Response Plan
183
Fact sheets
86
Training Material
82
Situation Updates
22
Infographics
14
Resource Platforms
12
Brochures
10
Online Courses
5
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
316
Global
207
Kenya
177
South Africa
134
Ethiopia
132
Uganda
131
Nigeria
119
Western and Central Europe
110
Tanzania
106
Nepal
101
Sierra Leone
92
Zambia
90
Liberia
89
Malawi
85
Africa
83
Myanmar / Burma
80
Latin America and the Carribbean
77
Ghana
75
Bangladesh
72
Rwanda
66
Namibia
61
Eastern Europe
58
Ukraine
57
Philippines
52
Asia
45
Zimbabwe
44
Cambodia
40
South–East Asia Region
40
Russia
38
Lesotho
37
Indonesia
31
Botswana
30
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Germany
19
Colombia
19
Brazil
18
East and Southern Africa
18
South Sudan
17
Cameroon
16
Haiti
15
West and Central Africa
15
USA
14
Middle East and North Africa
14
Tajikistan
13
Thailand
12
Venezuela
12
Albania
12
Pakistan
11
China
11
Vietnam
11
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Georgia
9
Sudan
8
Argentina
8
Sri Lanka
7
Paraguay
7
Armenia
7
Laos
7
Moldova
7
Mexico
6
Yemen
6
Western Pacific Region
6
North America
6
Iraq
5
Lebanon
5
Benin
5
Central African Republic
5
Peru
5
North Macedonia
5
El Salvador
5
Mali
4
Somalia
4
Jordan
4
Bhutan
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Turkey
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Libya
3
Angola
3
Madagascar
3
Fiji
3
Palestine
3
Kyrgyzstan
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Ecuador
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Estonia
2
Uzbekistan
2
Kazakhstan
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Greece
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Australia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2192
Clinical Guidelines
477
Public Health
271
Women & Child Health
216
Key Resources
159
Capacity Building
87
Pharmacy & Technologies
67
Annual Report MEDBOX
1
Toolboxes
HIV
674
Mental Health
551
TB
533
AMR
287
NTDs
244
COVID-19
207
Pharmacy
160
NCDs
119
Caregiver
111
Malaria
103
Ebola & Marburg
80
Planetary Health
78
Refugee
70
Disability
65
Rapid Response
65
Global Health Education
63
Conflict
58
Health Financing Toolbox
55
2.0 Rapid Response
28
Polio
22
Natural Hazards
20
Zika
17
Cholera
16
Specific Hazards
16
Social Ethics
15
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
BMJ Global Health Vol.4 (2019 no.4
The Drug Resistance Index (DRI) is proposed as measure of antibiotic effectiveness in a given country, by combining, in a single metric the use of various antibiotic groups and the resistance proportions of severa
...
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Perspectives on Drugs
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Revised Edition
Overview.
The COVID-19 pandemic is the latest crisis facing the world, but unless humans release their grip on nature, it won’t be the last, according to a new report by the United Nations Development Programme (UNDP), which includes a new experi
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Western Pac Surveill Response J. 2014 Oct-Dec; 5(4): 34–46.
Published online 2014 Dec 18. doi: [10.5365/WPSAR.2014.5.4.007]
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the WHO recommendations for the management of DR-TB, implement
...
Three Years After Enactment of the Drug Quality and Security Act